Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohort

REFERENCES

• Tanner JE, Alfieri C. The Epstein—Barr virus and post-transplant lymphoproliferative disease: interplay of immuno-suppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 2001;3:60 — 69.
   Google Scholar
• Hopwood P, Crawford DH. The role of EBV in posttransplant malignancies: a review. J Clin Pathol 2000;53:248–254.
   Google Scholar
• Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M et al. Posttransplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Hae-matologica 2002;87:67 —77.
   Google Scholar
• Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner PH, Swinnen JL, Woodle ES, Bromberg JS. Epstein-Barr virus-induced post-transplant lymphoproliferative disorders: ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Con-sensus Development Meeting. Transplantation 1999; 68:1517–1525.
   Google Scholar
• Craig FE, Gulley ML, Banks PM. Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 1993;99: 265–276.
   Google Scholar
• Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haema-tol 1995;89:98–103.
   Google Scholar
• Riddler SA, Breinig MC, McKnight JC. Increased levels of circulating Epstein- Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody response are associated with the development of post-transplant lympho-proliferative disease in solid organ transplant recipients. Blood 1994;84:972–984.
   Google Scholar
• Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant recipients and risk of lymphoproliferative disease. Blood 1994;83:2715–2722.
   Google Scholar
• Green M, Cacciarelli TV, Mazariegos G, Sigurdsson L, Qu L, Rowe DT, Reyes J. Serial measurement of Epstein-Barr virus load in peripheral blood in pediatric liver transplant recipients during treatment for post-transplant lymphoproliferative dis-ease. Transplantation 1998;66:1641–1644.
   Google Scholar
• Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-tranplant lymphoproliferative disease. Transplantation 1995;60:547–554.
   Google Scholar
• Muti G, Klersy C, Baldanti F, Granata S, Oreste P, Pezzetti L, Gatti M, Gargantini L, Caramella M, Mancini V et al. Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Br J Haematol 2003;122:927–933.
   Google Scholar
• van Snick J. Interleukin 6: an overview. Ann Rev Immunol 1990;8:253–278.
   Google Scholar
• Tosato G, Jones K, Breinig MK, McWilliams HP, McKnight JLC. Interleukin-6 production in post-transplant lymphopro-liferative disease. J Clin Invest 1993;91: 2806–2814.
   Google Scholar
• Tanner JE, Tosato G. Impairment of natural killer functions by interleukin-6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 1991;88:239–247.
   Google Scholar
• Birkeland SA, Bendtzen K, Muller B, Hamilton-Dutoit S, Andersen HK. Interleukin-10 and post-transplant lympho-proliferative disorder after kidney transplantation. Transplantation 1999;67: 876–881.
   Google Scholar
• Salazar-Onfray F. Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Med Oncol 1999;16:86–94.
   Google Scholar
• Mantel N. Synthetic retrospective studies and related topics. Biometrics 1973;29:479–490.
   Google Scholar
• Harris NL, Ferry JA, Swerdlow SH. Post-transplant lymphoproliferative disorders: summary of Society for Hae-matopathology workshop. Semin Diag Pathol 1997;14: 8–14.
   Google Scholar
• Telenti A, Marshall M, Smith TF. Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol 1990;28:2187–2190.
   Google Scholar
• Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. BioTechniques 1998;24:954–956.
   Google Scholar
• Yin JL, Shackel NA, Zekry A, McGuinness PH, Richards C, van der Putten K, McCayghan GW, Eris JM, Bishop GA. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR green I. Immunol Cell Biol 2001;79:213–221.
   Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915–924.
   Google Scholar
• Baiocchi OCG, Colleoni GWB, Caballero OL, Vettore AL, Andrade ALSS, Pestanan JOM. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort. Haematologica 2004;89:366–368.
   Google Scholar
• Stevens SJC, Verschuuren EAM, Verkuijlen SAWM, van der Brule AJC, Meijer CJLM, Middeldorp JM. Role of Epstein-Barr virus DNA monitoring in prevention and early detection of post-transplant lymphoproliferative disease. Leuk Lympho-ma 2002;43:831–840.
   Google Scholar
• Nalesnik MA, Zeevi A, Randhawa PS, Faro A, Spichty KJ, Demetris AJ, Fung jj, Whiteside TL, Starzl TE. Cytokine mRNA profiles in Epstein-Barr virus-associated post-trans-plant lymphoproliferative disorders. Clin Transplant 1999; 13:39–44.
   Google Scholar
• Durandy A. Anti-B cell and anti-cytokine therapy for the treatment of post-transplant lymphoproliferative disorder: past, present, and future. Transpl Infect Dis 2001;3:104–107.
   Google Scholar
• Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein-Barr virus B-cell lymphomas. Cancer Res 2003;63: 4472–4480.
   Google Scholar